Kari Stefansson

Professor

University of Iceland
Country flagIceland
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (9)

Obstructive sleep apnea (OSA) is a common, heritable disorder with diverse clinical presentations and etiologies. We conducted a genome-wide association meta-analysis of 492,107 individuals, including 46,028 OSA cases, identifying 14 genome-wide significant loci, eight of which are novel. Analyses adjusting for body mass index (BMI) revealed three loci independent of obesity, implicating alternative biological pathways contributing to disease. Integrative functional analyses, including chromatin interaction mapping, fine-mapping, and eQTL colocalization, prioritized candidate effector genes. Notably, implicated genes in chondrocytes were associated with craniofacial morphology in both mouse and human multivariate genotype-phenotype mapping, supporting a role for craniofacial structure in OSA risk. These findings highlight key genetic pathways (obesity-related, neurological, and craniofacial) underlying the development of OSA, offering new insights into its complex etiology.

Year:

2026

The North Sea’s historical migrations have impacted the genetic structure of its neighbouring populations. We analysed haplotype sharing among 858,635 modern individuals from Denmark and Britain to infer migration history from the Middle Ages to the modern day. We estimated the genetic relationship among 370,259 Danes using Danish healthcare registries and validated those with retrievable pedigree relationships from a national family registry. We also compared their haplotype sharing with 488,376 British individuals from the UK Biobank. Our analysis revealed the fine-grained population genetic history of Denmark and identified distinct coastal and island communities with a history of genetic isolation and bottlenecks. We observed a significant population decline in Jutland compared to Zealand from the late medieval period to the start of early modern period, accompanied by migration from Jutland to Zealand, corresponding to historical evidence. We identified two major haplotype sharing patterns between Denmark and Great Britain: (1) early coast-to-coast connections between South Jutland and eastern England, likely driven by migration, settlement, continuous trade and the movement of people across the North Sea from the Middle Ages through early modern times, and (2) later city-to-city connections such as those between London and København, likely shaped by the reorientation of economic and trading centres in Britain and Denmark, and the increased shipping from early modern times towards the Industrial Revolution. Further comparisons using other North Sea countries showed both shared and unique histories of genetic exchange with Denmark and Britain. Our study provides novel genetic evidence of migration across the North Sea from the Middle Ages to the Industrial Revolution. It highlights the power of nationwide biobanks in reconstructing fine-scale historical population movements among closely related populations.

Year:

2025

Psychiatric disorders display high levels of comorbidity and genetic overlap 1,2 . Genomic methods have shown that even for schizophrenia and bipolar disorder, two disorders long-thought to be etiologically distinct 3 , the majority of genetic signal is shared 4 . Furthermore, recent cross-disorder analyses have uncovered over a hundred pleiotropic loci shared across eight disorders 5 . However, the full scope of shared and disorder-specific genetic basis of psychopathology remains largely uncharted. Here, we address this gap by triangulating across a suite of cutting-edge statistical genetic and functional genomic analyses applied to 14 childhood- and adult-onset psychiatric disorders (1,056,201 cases). Our analyses identify and characterize five underlying genomic factors 6 that explain the majority of the genetic variance of the individual disorders (∼66% on average) and are associated with 268 pleiotropic loci. We observed particularly high levels of polygenic overlap 7 and local genetic correlation 8 and very few disorder-specific loci 9 for two factors defined by: ( i ) schizophrenia and bipolar disorder (“SB factor”), and by ( ii ) major depression, PTSD, and anxiety (“internalizing factor”). At the functional level, we applied multiple methods 10–12 which demonstrated that the shared genetic signal across the SB factor was substantially enriched in genes expressed in excitatory neurons, whereas the internalizing factor was associated with oligodendrocyte biology. By comparison, the genetic signal shared across all 14 disorders was enriched for broad biological processes (e.g., transcriptional regulation). These results indicate increasing differentiation of biological function at different levels of shared cross-disorder risk, from quite general vulnerability to more specific pathways associated with subsets of disorders. These observations may inform a more neurobiologically valid psychiatric nosology and implicate novel targets for therapeutic developments designed to treat commonly occurring comorbid presentations.

Year:

2025

Antidepressants exhibit a considerable variation in efficacy, and increasing evidence suggests that individual genetics contribute to antidepressant treatment response. Here, we combined data on antidepressant non-response measured using rating scales for depressive symptoms, questionnaires of treatment effect, and data from electronic health records, to increase statistical power to detect genomic loci associated with non-response to antidepressants in a total sample of 135,471 individuals prescribed antidepressants (25,255 non-responders and 110,216 responders). We performed genome-wide association meta-analyses, genetic correlation analyses, leave-one-out polygenic prediction, and bioinformatics analyses for genetically informed drug prioritization. We identified two novel loci (rs1106260 and rs60847828) associated with non-response to antidepressants and showed significant polygenic prediction in independent samples. Genetic correlation analyses show positive associations between non-response to antidepressants and most psychiatric traits, and negative associations with cognitive traits and subjective well-being. In addition, we investigated drugs that target proteins likely involved in mechanisms underlying antidepressant non-response, and shortlisted drugs that warrant further replication and validation of their potential to reduce depressive symptoms in individuals who do not respond to first-line antidepressant medications. These results suggest that meta-analyses of GWAS utilizing real-world measures of treatment outcomes can increase sample sizes to improve the discovery of variants associated with non-response to antidepressants.

Year:

2024

Mutations that affect RNA splicing significantly impact human diversity and disease. Here we present a method using transformers, a type of machine learning model, to detect splicing from raw 45,000-nucleotide sequences. We generate embeddings with residual neural networks and apply hard attention to select splice site candidates, enabling efficient training on long sequences. Our method surpasses the leading tool, SpliceAI, in detecting splice sites in GENCODE and ENSEMBL annotations. Using extensive RNA sequencing data from an Icelandic cohort of 17,848 individuals and the Genotype-Tissue Expression (GTEx) project, our method demonstrates superior performance in detecting splice junctions compared to SpliceAI-10k (PR-AUC = 0.834 vs. PR-AUC = 0.820) and is more effective at identifying disease-related splice variants in ClinVar (PR-AUC = 0.997 vs. PR-AUC = 0.996). These advancements hold promise for improving genetic research and clinical diagnostics, potentially leading to better understanding and treatment of splicing-related diseases.

Year:

2024

Mendelian Randomization studies indicate that BMI contributes to various diseases, but it’s unclear if this is entirely mediated by BMI itself. This study examines whether disease risk from BMI-associated sequence variants is mediated through BMI or other mechanisms, using data from Iceland and the UK Biobank. The associations of BMI genetic risk score with diseases like fatty liver disease, knee replacement, and glucose intolerance were fully attenuated when conditioned on BMI, and largely for type 2 diabetes, heart failure, myocardial infarction, atrial fibrillation, and hip replacement. Similar attenuation was observed for chronic kidney disease and stroke, though results varied. Findings were consistent across sexes, except for myocardial infarction. Residual effects may result from temporal BMI changes, pleiotropy, measurement error, non-linear relationships, non-collapsibility, or confounding. The attenuation extent of BMI genetic risk score on disease associations suggests the potential impact of reducing BMI on disease risk.

Year:

2024

Gene promoter and enhancer sequences are bound by transcription factors and are depleted of methylated CpG sites (cytosines preceding guanines in DNA). The absence of methylated CpGs in these sequences typically correlates with increased gene expression, indicating a regulatory role for methylation. We used nanopore sequencing to determine haplotype-specific methylation rates of 15.3 million CpG units in 7,179 whole-blood genomes. We identified 189,178 methylation depleted sequences where three or more proximal CpGs were unmethylated on at least one haplotype. A total of 77,789 methylation depleted sequences (~41%) associated with 80,503 cis -acting sequence variants, which we termed allele-specific methylation quantitative trait loci (ASM-QTLs). RNA sequencing of 896 samples from the same blood draws used to perform nanopore sequencing showed that the ASM-QTL, that is, DNA sequence variability, drives most of the correlation found between gene expression and CpG methylation. ASM-QTLs were enriched 40.2-fold (95% confidence interval 32.2, 49.9) among sequence variants associating with hematological traits, demonstrating that ASM-QTLs are important functional units in the noncoding genome.

Year:

2024

Two-thirds of all human conceptions are lost, in most cases before clinical detection. The lack of detailed understanding of the causes of pregnancy losses constrains focused counseling for future pregnancies. We have previously shown that a missense variant in synaptonemal complex central element protein 2 ( SYCE2 ), in a key residue for the assembly of the synaptonemal complex backbone, associates with recombination traits. Here we show that it also increases risk of pregnancy loss in a genome-wide association analysis on 114,761 women with reported pregnancy loss. We further show that the variant associates with more random placement of crossovers and lower recombination rate in longer chromosomes but higher in the shorter ones. These results support the hypothesis that some pregnancy losses are due to failures in recombination. They further demonstrate that variants with a substantial effect on the quality of recombination can be maintained in the population.

Year:

2024

This study aimed to uncover novel genes associated with neurodevelopmental disorders (NDD) by leveraging recent large-scale de novo burden analysis studies to enhance a virtual gene panel used in a diagnostic setting. We re-analyzed historical trio-exome sequencing data from 745 individuals with NDD according to the most recent diagnostic standards, resulting in a cohort of 567 unsolved individuals. Next, we designed a virtual gene panel containing candidate genes from three large de novo burden analysis studies in NDD and prioritized candidate genes by stringent filtering for ultra-rare de novo variants with high pathogenicity scores. Our analysis revealed an increased burden of de novo variants in our selected candidate genes within the unsolved NDD cohort and identified qualifying de novo variants in seven candidate genes: RIF1, CAMK2D, RAB11FIP4, AGO3, PCBP2, LEO1 , and VCP . Clinical data were collected from six new individuals with de novo or inherited LEO1 variants and three new individuals with de novo PCBP2 variants. Our findings confirm LEO1 as a risk gene for autism and intellectual disability. Furthermore, we prioritize PCBP2 as a candidate gene for NDD associated with motor and language delay. In summary, by leveraging de novo burden analysis studies, employing a stringent variant filtering pipeline, and engaging in targeted patient recruitment, our study contributes to the identification of novel genes implicated in NDDs.

Year:

2024

Collaborators (71)

Frank Kooy

Professor

University of Antwerp

BELGIUM
View details

Jordan Smoller

Professor

Massachusetts General Hospital

UNITED STATES
View details

Diego R. Mazzotti, Ph.D.

Associate Professor, Medical Informatics

University of Kansas Medical Center

UNITED STATES
View details

Peter A Cistulli

Professor of Sleep Medicine

University of Sydney

AUSTRALIA
View details

Soriul Kim

Assistant Professor

Korea University College of Medicine and School of Medicine

SOUTH KOREA
View details

Naomi Wray

University of Queensland

AUSTRALIA
View details

Laura Rasmussen-Torvik

Professor and Division Chief, Epidemiology

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Thorhildur Ólafsdóttir

University of Iceland

ICELAND
View details

Hafsteinn Einarsson

Head of the Faculty of Industrial Engineering, Mechanical Engineering and Computer Science

University of Iceland

ICELAND
View details

Søren Brunak

Professor of Disease Systems Biology, Research Director

Københavns Universitet

DENMARK
View details

Stephen V Faraone

Distinguished Professor

SUNY Upstate Medical University

UNITED STATES
View details

Gerome Breen

Professor of Psychiatric Genetics

King’s College London

UNITED KINGDOM
View details

G. Bragi Walters

Research Assistant Professor

University of Iceland

ICELAND
View details

Howard Edenberg

Distinguished Professor

Indiana University School of Medicine

UNITED STATES
View details

Karina Banasik

Associate Professor

Technical University of Denmark

DENMARK
View details

Christina Mikkelsen

-

DENMARK
View details

Susan Santangelo

Research Professor

Tufts University School of Medicine

UNITED STATES
View details

Ditte Demontis

Aarhus University

DENMARK
View details

Na Cai

Assistant Professor

ETH Zürich

SWITZERLAND
View details

Sisse Rye Ostrowski

Københavns Universitet

DENMARK
View details

Caroline Nievergelt

Professor

University of California, San Diego

UNITED STATES
View details

James Knowles

Distinguished Professor and Executive Director of the HGINJ

Rutgers University - Busch Campus

UNITED STATES
View details

Laufey Tryggvadottir

Professor

University of Iceland

ICELAND
View details

Joanna Biernacka

Associate Professor

Mayo Clinic

UNITED STATES
View details

Andrew Grotzinger

Associate Professor

Memorial University of Newfoundland

CANADA
View details

Benjamin Neale

Associate Professor

Broad Institute

UNITED STATES
View details

Kenneth S. Kendler

Professor

Virginia Commonwealth University

UNITED STATES
View details

Brittany Mitchell

Senior Research Fellow

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

David Westergaard

Associate Professor

Technical University of Denmark

DENMARK
View details

John Hettema

Professor

Texas A&M University

UNITED STATES
View details

Sara Hägg

Senior Researcher

Karolinska Institutet

SWEDEN
View details

Phil Lee

Associate Professor

Massachusetts General Hospital

UNITED STATES
View details

Oleksandr Frei

Associate Professor (20%)

University of Oslo

NORWAY
View details

Sandra Sanchez-Roige

Associate Professor

University of California, San Diego

UNITED STATES
View details

Murray Stein

Distinguished Professor

University of California, San Diego

UNITED STATES
View details

Michael Zuscik

Mack Clayton Professor, Vice Chair of Research, Director of the Colorado Program for Musculoskeletal Research

University of Colorado Anschutz Medical Campus

UNITED STATES
View details

Laura Thornton

Research Professor

University of North Carolina

UNITED STATES
View details

Miguel E. Rentería

Group Leader, Computational Neurogenomics Lab

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Laust Hvas Mortensen

Professor

University of Copenhagen

DENMARK
View details

H S Nielsen

Professor

Copenhagen University Hospital

DENMARK
View details

Sarah Medland

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Christian Erikstrup

Chair Professor

Aarhus University

DENMARK
View details

Joel Gelernter

Professor

Yale University School of Medicine

UNITED STATES
View details

Mette Nyegaard

Head of Department

Aalborg University

DENMARK
View details

Edoardo Errichiello

Assistant Professor

University of Pavia

ITALY
View details

Manuel Mattheisen

Associate Professor

Ludwig-Maximilians-Universität München

GERMANY
View details

Barbara Franke

Head of department

Radboud University Medical Center

NETHERLANDS
View details

Michael Gandal

William & Noreen Hetznecker Associate Professor

University of Pennsylvania

UNITED STATES
View details

Ásgeir Haraldsson

-

ICELAND
View details

Nicholas Martin

Senior Scientist and Senior Principal Research Fellow

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Lili Milani

Professor & Head of Estonian Biobank

University of Tartu

ESTONIA
View details

Josefin Werme

University of Amsterdam

NETHERLANDS
View details

Thomas Folkmann Hansen

Professor

Technical University of Denmark

DENMARK
View details

Runolfur Palsson

Professor of Medicine (Kidney Diseases)

University of Iceland

ICELAND
View details

Karen Mitchell

Assistant Professor

Boston University

UNITED STATES
View details

Anne Justice

Associate Professor

Geisinger Health

UNITED STATES
View details

Elliot M. Tucker-Drob

Faculty Research Associate

University of Texas at Austin

UNITED STATES
View details

Ole A. Andreassen

Oslo University Hospital

NORWAY
View details

Ole Birger Pedersen

Professor

Zealand University Hospital

DENMARK
View details

Irwin Waldman

Professor

Emory University

UNITED STATES
View details

Brandon Coombes

Assistant Professor of Biostatistics

Mayo Clinic

UNITED STATES
View details

Timothy Morgenthaler

Professor of Medicine

Mayo Clinic

UNITED STATES
View details

Chol Shin

Seoul National University Hospital

SOUTH KOREA
View details

Wouter Peyrot

VU medisch centrum

NETHERLANDS
View details

Sigrún Helga Lund

Professor

University of Iceland

ICELAND
View details

Katherine Jonas

Assistant Professor

Stony Brook University

UNITED STATES
View details

Bhajan Singh

University of Western Australia

AUSTRALIA
View details

Aylwyn Scally

Group leader

University of Cambridge

UNITED KINGDOM
View details

Eva Hoffmann

Professor

Københavns Universitet

DENMARK
View details

Yi Lu

Karolinska Institutet

SWEDEN
View details

John Nurnberger

Professor/Distinguished Professor

Indiana University School of Medicine

UNITED STATES
View details